Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'

June 10, 2026 7:10 AM

(Updated - June 10, 2026 7:34 AM EDT)

Barclays analyst Andrew Mok upgraded Oscar Health Inc (NYSE: OSCR) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'

Categories